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Objective. To determine if a global mid-upper arm circumference (MUAC) cutoff can be 2 
established to classify underweight in adults (men and non-pregnant women).  3 
Design. We conducted an individual participant data meta-analysis (IPDMA) to explore the 4 
sensitivity (SENS) and specificity (SPEC) of various MUAC cutoffs for identifying underweight 5 
among adults (defined as body mass index (BMI) <18.5 kg/m2). Measures of diagnostic accuracy 6 
were determined every 0.5 cm across MUAC values from 19.0 to 26.5 cm. A bivariate random 7 
effects model was used to jointly estimate SENS and SPEC while accounting for heterogeneity 8 
between studies. Various subgroup analyses were performed. 9 
Setting. Twenty datasets from Africa, South Asia, Southeast Asia, North America, and South 10 
America were included.  11 
Participants. All eligible participants from the original datasets were included. 12 
Results. The total sample size was 13,835. Mean age was 32.6 years and 65% of participants 13 
were female. Mean MUAC was 25.7 cm and 28% of all participants had low BMI (<18.5 kg/m2). 14 
The area under the receiver operating characteristic curve (AUROC) for the pooled dataset was 15 
0.91 (range across studies: 0.61-0.98). Results showed that MUAC cutoffs in the range of ≤23.5 16 
cm to ≤25.0 cm could serve as appropriate screening indicators for underweight.  17 
Conclusions. MUAC was highly discriminatory in its ability to distinguish adults with BMI 18 
above and below 18.5 kg/m2. This IPDMA is the first step towards determining a global MUAC 19 
cutoff for adults. Validation studies are needed to determine whether the proposed MUAC cutoff 20 
of 24 cm is associated with poor functional outcomes.  21 
 22 
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Body mass index (BMI) is a widely used measure of nutritional status in adults. The 26 
World Health Organization (WHO) has established global BMI cutoffs for adults over 20 years 27 
of age with the range <18.5 kg/m2 indicating underweight. Although several recent and large 28 
pooled and meta-analytic studies show a shift in focus towards examining the adverse health 29 
effects of high BMI levels, these studies continue to show elevated morbidity and mortality in 30 
the lowest ranges of BMI. (1-5) In many resource-limited or emergency settings, accurate 31 
measurements of BMI may be difficult to obtain due to lack of access to properly maintained 32 
equipment (weight scales and stadiometers). In addition, health workers must be trained to read 33 
relatively complicated charts to convert weight and height measurements to BMI.   34 
Mid-upper arm circumference (MUAC) is a potential alternative measure to BMI to 35 
screen for adult underweight. MUAC is a measure of the circumference of the upper arm at the 36 
midpoint between the tip of the elbow (olecranon process) and tip of the shoulder blade 37 
(acromion process).(6) While MUAC measurements are generally a reflection of both muscle and 38 
subcutaneous fat, in undernourished individuals who tend to have smaller amounts of 39 
subcutaneous fat, MUAC measurements can reflect chronic energy deficiency.(6) MUAC 40 
measurements are linear and can be taken with a simple tape measure. With appropriate MUAC 41 
cutoffs, the assessment could be performed by anyone with minimal training using even a simple 42 
paper strip that designates the cutoff values using color codes.  43 
In 2013, we completed a systematic review examining low MUAC as an indicator or 44 
predictor of nutrition and health outcomes in adults and adolescents.(7) Our review found that 45 
MUAC correlates well with BMI in adult populations and that people with low MUAC (variably 46 
defined by the original studies) are significantly more likely to have low BMI (<18.5 kg/m2).(8-11) 47 
Low MUAC was also shown to be a significant predictor of short-term mortality.(12-14) Yet 48 
globally recognized MUAC cutoffs have not been established to classify underweight among 49 
adults. Within the past decade, countries and programs, particularly those working in the fields 50 
of human immunodeficiency virus (HIV) and tuberculosis (TB), have tried to establish their own 51 
MUAC cutoffs to determine eligibility for program services, but there is limited evidence that 52 
these cutoffs are optimal for identifying individuals who are undernourished and who are at 53 




To date, there is no guidance from the WHO about what MUAC cutoff should trigger 55 
further action in adults. However, WHO has recommended a MUAC cutoff of <11.5 cm as a 56 
screening tool for acute malnutrition in children 6 to 60 months of age.(18) This cutoff has 57 
become a globally recognized standard for the identification and management of severe acute 58 
malnutrition in children and is often used to determine eligibility for, and to monitor progress in, 59 
facility-based and community-level nutritional interventions.(19) Global MUAC cutoffs for adults 60 
could also serve to strengthen and harmonize programming across various sectors, including 61 
HIV, TB, and broader community health and nutrition activities. 62 
To determine the potential for developing standardized MUAC cutoffs to identify adults 63 
at risk of undernutrition, we undertook an individual participant data meta-analysis (IPDMA) to 64 
examine the diagnostic accuracy of various MUAC cutoffs for identifying underweight 65 
(BMI<18.5 kg/m2) among men and non-pregnant women, henceforth referred to simply as “non-66 
pregnant adults.” In our systematic review, BMI <18.5 kg/m2 was the outcome most consistently 67 
found to be associated with low MUAC. The decision to conduct meta-analyses using individual-68 
level data rather than study-level (published) data was primarily dictated by the fact that most of 69 
the published studies did not examine or provide data on the sensitivity or specificity of various 70 
MUAC cutoffs.(7) An original report which included 17 studies was published online in June 71 
2017.(20) The current paper extends the findings of this report by including three additional 72 
datasets obtained after the report was finalized. 73 
 74 
Methods 75 
Prior to seeking datasets, eligibility criteria and an analysis plan were established and 76 
approved through our technical advisory group (TAG), which consisted of members from the 77 
National Institutes of Health (NIH), the United States Agency for International Development 78 
(USAID), and the World Health Organization (WHO). To be eligible for the IPDMA, datasets 79 
had to include non-pregnant adults over the age of 18, with a minimum sample size of 100, and 80 
be collected on or after the year 2000. We chose the year 2000 because that was the year that 81 
antiretroviral therapy for HIV became widely accessible to people living with HIV in low-82 
resource settings. In addition, investigators had to be willing to share participant-level data. The 83 





Of the 13 studies that were included in our systematic review(7), three were not eligible 86 
for this IPDMA: one was conducted prior to 2000(8) and two had sample sizes fewer than 100.(21, 87 
22)  We attempted to contact researchers from the remaining 10 studies and ultimately received 88 
datasets from two of them. One researcher provided two eligible datasets (GUI-HIV and GUI-89 
TBC) and another research group provided six eligible datasets (IND-BKW, IND-FSD, IND-90 
MSD, IND-ORA, IND-SDW, and IND-UNI). We then put out a call for datasets through our 91 
technical advisory group (TAG) and updated our literature search. Through these methods, we 92 
were able to obtain six additional datasets (BAN, MAL-HNW, MAL-HWW, SAF, VIE-FEM, 93 
and ZAM). We also included six eligible datasets from the Tufts team commissioned to conduct 94 
the IPDMA (ARG, IND-IDU, NAM, USA-IDU, USA-HIV, and VIE-IDU. Thus, the present 95 
analysis includes data from 20 unique datasets. Data from four studies (IND-UNI, MAL-HNW, 96 
NAM, and ZAM) were unpublished at the time this manuscript was written. Table 1 provides a 97 
brief summary of the studies included in this IPDMA. The twenty studies represent the target 98 
populations that would most likely use an established low MUAC cutoff to determine eligibility 99 
for limited health and nutrition services, i.e. people living with HIV and/or TB, low-resource and 100 
development settings, and individuals at risk of undernutrition (e.g. injection drug users). 101 
 102 
Statistical Analyses 103 
All datasets were converted and analyzed using the Stata statistical software (StataCorp, 104 
College Station, TX, USA). Each dataset was assessed against published manuscripts or original 105 
research protocols to create an overview of the included participants and study procedures. For 106 
each dataset, we performed data checks of all variables received, ensuring that units, categories, 107 
coding, and labels were consistent across studies. Investigators were contacted to confirm 108 
missing data, to check extreme or invalid values, and to obtain clarification of study variables 109 
and procedures.  110 
To better understand the data from each individual study and the degree of potential 111 
heterogeneity between studies, basic descriptive statistics were calculated for each study. These 112 
variables included age, sex, education level, HIV status, MUAC, height, weight, and BMI. The 113 
collection of information on education was not consistent across studies. Some studies asked for 114 
the number of years of schooling, while others collected data in predetermined categories which 115 




levels across studies, we created three general categories: no education, education at or up to the 117 
primary school level (grades 1 to 8, 1–8 years of schooling, or less than high school), and 118 
education at or above the secondary school level (grades 9 to ≥12, ≥9 years of schooling, 119 
completion of high school or beyond).  120 
MUAC was measured to the nearest 0.1 cm in all studies except for GUI-TBC, where 121 
MUAC was measured to the nearest 0.2 cm. Histograms of MUAC and BMI were constructed to 122 
determine the distribution of these measurements for each study separately and for all datasets 123 
combined (Supplementary Figures 1 to 4). Scatterplots of BMI by MUAC were examined to 124 
determine the association between the two variables, for each study separately and for all 125 
datasets combined (Supplementary Figures 5 and 6). Pearson correlation coefficients between 126 
MUAC and BMI were calculated for each study separately and for all studies combined. The 127 
outcome of low BMI was defined as BMI <18.5 kg/m2, consistent with the cutoff for 128 
underweight recommended by the WHO.(23) 129 
We then examined the diagnostic accuracy of MUAC in predicting low BMI, using 130 
MUAC cutoffs in increments of 0.5 cm over the range of 19.0 to 26.5 cm. For each MUAC 131 
cutoff, we constructed a 2x2 table showing the cross-tabulation of BMI category (BMI <18.5 vs. 132 
BMI ≥18.5) and MUAC (above or below the specified cutoff). We computed sensitivity (SENS), 133 
specificity (SPEC), positive predictive value (PPV), and negative predictive value (NPV) over 134 
the range of MUAC cutoffs for each of the 20 datasets. We also obtained the area under the 135 
receiver operating characteristic curve (AUROC) for each study. Next, we combined the datasets 136 
into one pooled dataset and created a unique participant identification number and study 137 
identifier variable to identify participants within studies.  We estimated SENS, SPEC, and 138 
positive and negative Likelihood Ratios (LR+ and LR-) for each MUAC cutoff value using the 139 
user-written metandi and midas commands in Stata.(24, 25) These commands perform a bivariate 140 
(or joint) meta-analysis of SENS and SPEC using a two-level mixed-effect logistic regression 141 
model with MUAC as the only independent variable predicting low BMI. At the first level, 142 
within-study variability is accounted for by modeling the counts of the 2x2 tables within each 143 
study. At the second level, the between-study variability (heterogeneity) is accounted for, 144 
allowing for the non-independence of SENS and SPEC across studies. We also obtained the 145 






The number of participants in each study ranged from 182 (ZAM) to 4,926 (VIE-FEM) 149 
(Table 1). The VIE-FEM dataset was by far the largest, with nearly five times the number of 150 
participants as the second largest dataset (GUI-HIV, with n=1,055).  151 
Table 2 shows the demographic characteristics of the participants, by individual study 152 
and for all studies combined. Overall, the mean age was 32.6±12.1 years, with ages ranging from 153 
18 to 91 years. The average age for each study was predominantly in the 30s, with a few 154 
exceptions. Three studies targeted slightly younger populations (BAN, IND-UNI, and VIE-155 
FEM), and two studies included slightly older participants (USA-IDU and USA-HIV). One study 156 
(SAF) specifically targeted an elderly population and thus had a mean age of 71.5±7.9 years.  157 
Nearly two-thirds of participants in the pooled dataset were female (64.4%). Two studies 158 
(IND-FSD and VIE-FEM) included only female participants and five studies (IND-BKW, IND-159 
MSD, IND-ORA, IND-IDU, and VIE-IDU) included only male participants.  160 
Six of the 17 studies did not collect data on education status. Of the remaining 11 studies, 161 
education level differed widely between studies. Two studies (IND-BKW and IND-FSD) 162 
included a majority of participants that had no schooling. Two studies (ARG and IND-IDU) 163 
included a majority of participants with primary school education, and six studies (GUI-TBC, 164 
IND-UNI, NAM, USA-HIV, VIE-FEM, and VIE-IDU) included a majority with secondary 165 
school education or above.  166 
HIV status was not ascertained in half of the studies. Five studies (GUI-HIV, MAL-167 
HNW, MAL-HWW, USA-HIV, and ZAM) included HIV-positive participants only and the 168 
remaining five studies (ARG, IND-IDU, NAM, USA-IDU, and VIE-IDU) included both HIV-169 
positive and HIV-negative participants.  170 
Table 3 shows the MUAC and BMI measurements by individual study and for all studies 171 
combined. MUAC measurements ranged from a low of 11.6 cm in GUI-HIV to a high of 57.0 172 
cm in USA-HIV. The average MUAC measurement varied between studies, ranging from 19.7 173 
cm in MAL-HWW to 32.7 cm in SAF. Overall, 28.4% of participants had low BMI (<18.5 174 
kg/m2). Prevalence of low BMI ranged from approximately 5% or less in six studies (ARG, GUI-175 
TBC, MAL-HNW, SAF, USA-HIV, and USA-IDU) to 89% in two studies (MAL-HWW and 176 
ZAM). Supplementary Figures 5 and 6 show the scatterplots of BMI by MUAC for each study 177 




significant for all studies, ranging from 0.45 (IND-ORA) to 0.89 (SAF). Fourteen of the 20 179 
studies had correlation coefficients at or above 0.80. For the pooled dataset, the correlation 180 
coefficient was 0.85 (p<.00001). The ROC curve for the pooled dataset (Figure 1) indicates clear 181 
discrimination between the distributions of MUAC measurements among those with low BMI 182 
compared to those with normal to high BMI. The ROC curve approaches the upper left-hand 183 
corner of the graph, indicating high SENS is achieved with high SPEC. AUROC ranged from 184 
0.61 (ZAM) to 0.98 (ARG and USA-HIV), with 13 of the 20 values being ≥0.90 (Table 3). 185 
AUROC for the pooled dataset was 0.91.  186 
Supplementary Tables 2 to 17 compare SENS, SPEC, PPV, and NPV for predicting low 187 
BMI across studies for each MUAC cutoff from 19.0 cm to 26.5 cm, in increments of 0.5 cm. As 188 
shown, the values of SENS, SPEC, PPV, and NPV at each MUAC cutoff varied widely between 189 
studies.  190 
Table 4 shows the summary estimates of SENS, SPEC, positive and negative likelihood 191 
ratios (LR+ and LR-) derived from the bivariate random-effects model. SENS and SPEC ranged 192 
from 4.9% and 99.7%, respectively, at a MUAC cutoff of 19.0 cm to 98.0% and 51.0%, 193 
respectively, at a MUAC cutoff of 26.5 cm. The MUAC cutoff with the highest SENS at or 194 
above a SPEC of 70% was 25.0 cm. However, cutoffs with lower (but still acceptable) SENS 195 
values and higher SPEC values could extend down to 23.0 cm. For example, a cutoff of 23.0 cm 196 
would misclassify 35% of those with BMI <18.5 kg/m2 as being adequately nourished and 7% of 197 
individuals with BMI ≥18.5 kg/m2 as being undernourished. Based on the likelihood ratios, a 198 
person with BMI <18.5 kg/m2 is 9.7 times more likely to have a MUAC ≤23.0 cm than an 199 
individual with BMI ≥18.5 kg/m2, and a person with BMI <18.5 kg/m2 is 60% less likely to have 200 
a MUAC >23.0 cm than a person with BMI ≥18.5 kg/m2.  A higher cutoff of 25.0 cm would 201 
correctly classify 93% of individuals with low BMI as being undernourished but would 202 
misclassify approximately 27% of those with BMI ≥18.5 kg/m2. Based on the likelihood ratios, a 203 
person with BMI <18.5 kg/m2 is 3.5 times more likely to have a MUAC ≤25.0 cm and 90% less 204 
likely to have a MUAC >25.0 cm than an individual with BMI ≥18.5 kg/m2. 205 
Table 5 compares the results obtained from various sensitivity and subgroup analyses that 206 
we conducted. Nine studies had either a low prevalence (<10%) of individuals with BMI <18.5 207 
or a low prevalence (<11%) of individuals with normal to high BMI, resulting in less stable 208 




and found that, compared to the full dataset, SENS increased and SPEC decreased across all 210 
MUAC cutoffs. We obtained very similar results when excluding five upper middle or high-211 
income countries (ARG, NAM, SAF, USA-HIV, AND USA-IDU) from the analyses. Subgroup 212 
analyses by sex and HIV status found that SENS was higher and SPEC lower in females and 213 
people living with HIV than their male or HIV-negative counterparts.  214 
 215 
Discussion 216 
The purpose of this IPDMA was to determine whether a global MUAC cutoff could be 217 
recommended as a screening tool to assess underweight in nonpregnant adults. Currently, the 218 
screening tool most commonly used to determine underweight is low BMI (<18.5 kg/m2). 219 
However, the measurement of BMI requires equipment (weight scales and stadiometers) that 220 
needs to be properly set-up and maintained, and skilled individuals to measure the height and 221 
weight and calculate the BMI. For these reasons, in settings where obtaining accurate 222 
measurements of BMI is not feasible, a simple identification of low MUAC could serve as a 223 
surrogate for low BMI. Using 20 compiled datasets from various parts of the world, we found 224 
that MUAC has an excellent ability to discriminate between those with low BMI (<18.5 kg/m2) 225 
and those with normal to high BMI (≥18.5 kg/m2). The results remained robust across the 226 
various sensitivity and subgroup analyses we performed.  We found that, although individual 227 
measures of SENS and SPEC at each of the MUAC cutoffs varied between studies, the 228 
diagnostic accuracy of MUAC for identifying adults with low BMI was consistently high. 229 
AUROCs ranged from 0.61 to 0.98 for individual studies, with most studies having values ≥0.90. 230 
The AUROC was 0.91 for all studies combined, which is considered to be in the “excellent” 231 
range based on general interpretations for the AUROC.(26) Results of the meta-analysis showed 232 
that MUAC cutoffs in the range of 23.5 cm to 25.0 cm could potentially serve as appropriate 233 
indicators for low BMI, with acceptable levels of SENS and SPEC at each of these cutoffs for 234 
the purpose of initial screening for underweight in the community or in a clinical setting. MUAC 235 
cutoffs in the range of 24.0 cm to 25.0 cm provided optimal levels of SENS and SPEC for many 236 
of the subgroups analyzed.  237 
The selection of the optimal MUAC cutoff for identifying moderate and severe 238 
undernutrition in non-pregnant adults must take into consideration the tradeoff between failing to 239 




individuals who are not in need of services to the health care system or program (false positive 241 
rate). At a MUAC cutoff of 24.0 cm, SENS was 84% and SPEC was 83%. At this cutoff, the 242 
false negative and false positive rates would be 16% and 17%, respectively. Lowering the 243 
MUAC cutoff to 23.5 cm would increase the false negative rate to 25% and decrease the false 244 
positive rate to 11%. At a MUAC cutoff of 25.0 cm, SENS increased to 93% and SPEC 245 
decreased to 73%, lowering the false negative rate to 7%, but increasing the false positive rate to 246 
27%.  247 
The recommendation for a MUAC cutoff (or a range of cutoffs) based on this IPDMA is 248 
only a first step towards determining a standardized and global MUAC cutoff to identify 249 
undernutrition among nonpregnant adults. While many countries and programs currently use low 250 
MUAC as a tool for assessing nutritional status and determining eligibility for limited nutrition 251 
interventions, the lack of a standardized cutoff makes it difficult to compare studies 252 
internationally and to evaluate the effect of nutritional interventions in larger contexts. The 253 
widespread collection and reporting of outcomes based on a single standardized MUAC cutoff 254 
would facilitate better understanding of the effectiveness of MUAC as a screening tool for adult 255 
underweight in various contexts and settings. It is important to note that the purpose of nutrition 256 
assessment is to identify individuals who are at risk of malnutrition and who would benefit from 257 
nutrition and/or clinical intervention. WHO defines malnutrition as “deficiencies, excesses or 258 
imbalances in a person’s intake of energy and/or nutrients”.(27) Others have defined malnutrition 259 
as “a subacute or chronic state of nutrition in which a combination of varying degrees of over- or 260 
under-nutrition and inflammatory activity have led to a change in body composition and 261 
diminished function”.(28) A comprehensive nutrition assessment therefore requires several 262 
elements, including: 1) evaluation of an individual’s history and clinical diagnoses; 2) physical 263 
examination for signs of malnutrition (e.g., edema or specific nutrient deficiencies) and/or 264 
clinical indicators of inflammation (fever, hypothermia, tachycardia); 3) anthropometric data, 265 
such as weight, BMI, skinfolds, or circumferences; 4) evaluation of usual dietary intake; 5) 266 
laboratory indicators if available (e.g., C-reactive protein, white blood cell count, glucose); and 267 
6) functional outcomes, such as strength and mobility.(29) As it is not feasible to conduct a 268 
complete nutrition assessment on every individual in a community, or even on every individual 269 
who enters a health care facility, valid screening tools that are simple, quick, acceptable, and 270 




and clinic settings to accurately identify individuals who are at highest risk of undernutrition 272 
leading to impaired function and poor clinical outcomes, and for whom intervention would 273 
improve their nutritional status and clinical outcomes and restore function. It is important to keep 274 
in mind that no one screening tool is optimal for all individuals in all situations. Each has its 275 
strengths and limitations in different contexts, and each can be affected by an individual’s 276 
clinical status. Therefore, screening tools such as low MUAC should only be used as an initial 277 
step that triggers further and more detailed nutrition assessment, followed by intervention if 278 
appropriate. Although programs and policymakers will need to consider available resources 279 
when deciding on the optimal MUAC cutoff, we propose that in the context of initial screening 280 
under ideal situations, a high SENS (low false negative rate) is more critical than a high SPEC 281 
(low false positive rate).  282 
This study had some limitations. Our initial systematic review identified 10 potentially 283 
eligible datasets of which we were only able to obtain two for the IPDMA. The remaining 284 
datasets in this analysis were obtained from our own research studies, through referrals from our 285 
TAG, and through further solicitation of studies in the literature that included MUAC as a 286 
continuous measure (our systematic review included only studies that analyzed MUAC as a 287 
binary/categorical variable). Therefore, in the end, we were not able to use a formal systematic 288 
process for identifying all the datasets included in this analysis. In addition, although a large 289 
variety of geographical regions and settings were represented in this analysis, the datasets we 290 
obtained may not be representative of those regions or settings. Unfortunately, national nutrition 291 
surveys that would be representative of our target population, such as the Demographic Health 292 
Surveys, do not routinely collect MUAC in adults. Furthermore, readers should use caution when 293 
interpreting the results, which may be affected by confounders, both measured and unmeasured. 294 
For example, the presence of edema, which was not measured in most datasets, is a likely 295 
confounder in the association between MUAC and BMI.   296 
We posited that the applicability of our IPDMA results may be limited due to 297 
heterogeneity in population characteristics, specifically the wide variability in prevalence of low 298 
BMI. Leeflang et al. have proposed several contexts in which SENS and SPEC can vary with 299 
disease prevalence (contrary to what is commonly taught in epidemiology courses), including the 300 
use of an imperfect reference standard, such as low BMI.(30, 31) We used meta-regression 301 




cutoffs of 24.0 and 25.0 cm as examples. For both cutoffs, we found that very little of the 303 
variability in SENS was due to the variation in prevalence of low BMI (Adjusted R2=5.3% for 304 
MUAC ≤24.0 and 1.9% for MUAC ≤25.0 (Supplemental Figure 7)). However, nearly one-third 305 
to one-half of the variation in SPEC was due to the variation in low BMI prevalence (Adjusted 306 
R2=48.3% for MUAC ≤24.0 and 31.9% for MUAC ≤25.0). In sensitivity analyses removing the 307 
nine studies with low prevalence of BMI <18.5 kg/m2 or BMI≥18.5 kg/m2, the proportion of 308 
variability in SPEC due to the variation in low BMI prevalence was reduced to 0% for both 309 
MUAC cutoffs (Supplemental Figure 8). The remaining variability, which is larger for SPEC 310 
than for SENS, is due to unknown factors.   311 
One of the unknown factors contributing to this variability could be ethnicity. Much of 312 
the literature examining ethnic differences in body composition has focused on the associations 313 
between BMI, adiposity, and health risks associated with overweight and obesity.(32-35)  Ethnic 314 
differences in the effect of undernutrition on the relative loss of fat from the limbs and trunk is 315 
largely unknown. To our knowledge, very little is published on ethnic differences in MUAC 316 
measurements, particularly among undernourished adults. In children 6 to 60 months of age, one 317 
study suggests that the association between MUAC<11.5 cm and mortality may be modified by 318 
ethnicity.(36) It is quite possible that the association between MUAC cutoffs and low BMI differs 319 
by ethnicity; however our dataset was not robust enough to examine this. Readers can examine 320 
differences by countries and geographic regions in the supplementary tables provided, but we 321 
were not able to compare different ethnicities within or across datasets. Large scale studies in 322 
each population or country would be required to determine whether a low MUAC cutoff might 323 
differ by ethnicity. In addition, further consideration should be given to the implications of 324 
establishing different cutoffs for different subgroups (whether it be by ethnicity, age, or disease 325 
group) as this would hinder comparisons across countries and would be impractical for 326 
community-level screening. 327 
Based on our results, we propose that a MUAC cutoff of 24.0 cm meets the criterion for 328 
optimizing SENS and SPEC across various subpopulations when assessed against low BMI. A 329 
meaningful MUAC cutoff would be one below which function and clinical outcomes deteriorate. 330 
Whether a MUAC cutoff of 24.0 cm fits this criterion needs to be tested and validated in future 331 
longitudinal studies. Comparisons of MUAC against measures such as lean body mass or grip 332 




screening tool for undernutrition. As a valid and reliable screening tool, the use of MUAC in 334 
place of BMI would reduce the amount of time and technical skill required for nutrition 335 
screening in community settings, resulting in a larger number of individuals who would benefit 336 
from further nutrition assessment and intervention. We stress that the proposed MUAC cutoff is 337 
currently only intended for use as a screening tool to trigger referral for further assessment; it is 338 
not recommended to be used for diagnosis or as an entry criterion into food or nutrition 339 
supplementation programs until further validation studies with clinical outcomes have been 340 
conducted. 341 
Finally, although the focus of this report is on adult underweight, we do acknowledge the 342 
growing global burden of overweight and obesity at both the individual and population level, and 343 
the need for screening tools to help prioritize the limited services that are available in low-344 
resource settings. Therefore, future studies should also explore MUAC as a potential screening 345 
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Brief Study Description 
Sample 
Sizeb 
ARG(37) Argentina 2005–2006 HIV-positive and HIV-negative drug users in Buenos Aires, Argentina 204 
BAN(38) Bangladesh 2012 
Patients of the Dhaka Hospital of the International Centre for Diarrheal Disease Research, 
Bangladesh 
650 
GUI-HIV(13) Guinea-Bissau 2007–2009 Antiretroviral therapy (ART)-naïve, HIV-infected patients in Guinea-Bissau 1,055 
GUI-TBC(39) Guinea-Bissau 2014 Healthy controls and household contacts of tuberculosis (TB) patients in Guinea-Bissau 769 
IND-BKW(40) India 2014-2016 Adult male brick-kiln workers in Murishdabad district, West Bengal, India 501 
IND-FSD(9) India 2006 Female slum dwellers in Midnapore Town, West Bengal, India 333 
IND-IDU(41) India 2007 Current and former male injection drug users (IDUs) in Chennai, Tamil Nadu, India 374 
IND-MSD(10) India 2003–2004 Male slum dwellers in Kolkata, India 474 
IND-ORA(42) India 2007 Oraon men of Gumla District, Jharkhand, India 205 
IND-SDW(43) India 2015-2017 Male and female slum dwellers in Midnapore Town, Paschim Midnapore, West Bengal, India  992 
IND-UNIa India 2013–2014 University students in Midnapore Town, West Bengal, India 599 
MAL-HNWa Malawi 2008–2010 
ART-naïve, HIV-infected adults without wasting in three districts in Malawi (Lilongwe, Mzuzu, 
and Kasungu) 
329 
MAL-HWW(44) Malawi 2006–2007 ART-naïve, HIV-infected adults with wasting and MUAC <22.0 cm in Mangochi, Malawi 186 
NAMa Namibia 2014 Adults recruited from bar district in Windhoek, Namibia 407 
SAF(45) South Africa 2002 Free-living and institutionalized elderly black South Africans in Cape Town, South Africa 283 
USA-HIV(46) USA 2001–2013 HIV-infected adults in the Greater Boston area, United States 553 
USA-IDU(47) USA 2005–2007 Current and former IDUs in the United States in Boston, MA; Baltimore, MD; and Providence, RI 520 
VIE-FEM(48) Vietnam 2011–2012 Nonpregnant females of reproductive age in Thai Nguyen Province, Vietnam 4,926 
VIE-IDU(49) Vietnam 2006–2008 Current and former male IDUs in Hanoi, Vietnam 297 
ZAMa Zambia 2009–2010 HIV-infected adults with wasting in Lusaka, Zambia 182 
a Study has not been published yet. See Supplementary Table 1 for more complete descriptions of unpublished studies. 
b This refers to the total number of observations with MUAC measurements. Missing values on individual variables (e.g., BMI) may slightly reduce the numbers for 




Table 2. Participant characteristics, by individual study and for all studies combined 
STUDY ID N 
Age (years)a Sexb Educationc,d 
HIV(+)e 











ARG 204 18.4-50.6 31 (7.1) 179 (88) 25 (12) 8 (4) 159 (78) 37 (18) 69 (34) 
BAN 650 19-60 27.7 (7.4) 260 (40) 390 (60) 171 (26) 194 (30) 285 (44) Not tested 
GUI-HIV 1055 18-76 37.5 (10.9) 313 (30) 742 (70) No Data 1,055 (100) 
GUI-TBC 769 18-90 33.1 (13.8) 335 (44) 434 (56) 101 (13) 240 (31) 428 (56) Not tested 
IND-BKW 501 18-74 36.6 (11.6) 501 (100) 0 (0) 338 (68) 40 (8) 123 (25%) Not tested 
IND-FSD 333 18-80 34.2 (14) 0 (0) 333 (100) 196 (59) 123 (37) 14 (4) Not tested 
IND-IDU 374 22-61 38.7 (7.2) 374 (100) 0 (0) 85 (23) 222 (59) 67 (18) 178 (48) 
IND-MSD 474 18-84 37.5 (14.2) 474 (100) 0 (0) 136 (29) 148 (31) 190 (40) Not tested 
IND-ORA 205 18-70 38 (13.4) 205 (100) 0 (0) No Data Not tested 
IND-SDW 992 18-85 35.9 (14.5) 490 (49) 502 (51) 368 (37) 239 (24) 384 (38) Not tested 
IND-UNI 599 18-28 22.1 (1.6) 228 (38) 371 (62) 0 (0) 0 (0) 599 (100)  Not tested 
MAL-HNW 329 18-57 33.9 (8.1) 122 (37) 206 (63) No Data 329 (100) 
MAL-HWW 186 18-58 34.1 (9) 56 (30) 130 (70) No Data 186 (100) 
NAM 407 18-74 29.9 (9.7) 236 (58) 171 (42) 36 (9) 39 (10) 331 (82) 73 (18) 
SAF 283 60-91 71.5 (7.9) 53 (19) 230 (81) No Data Not tested 
USA-HIV 553 24.1-75.4 46.1 (7.9) 372 (67) 181 (33) 0 (0) 6 (1) 547 (99)  553 (100) 
USA-IDU 520 22-67.8 43.8 (7.5) 335 (64) 185 (36) 187 (36) 206 (40) 123 (24) 284 (55) 
VIE-FEM 4922 18-44.7 26.4 (4.5) 0 (0)  4922 (100) 0 (0) 404 (8) 4516 (92) Not tested 
VIE-IDU 297 19-46.9 31.2 (5.2) 297 (100)  0 (0) 1 (0) 3 (1) 293 (99) 202 (68) 
ZAM 182 20-49 33.2 (7.7) 91 (50) 91 (50) No Data 182 (100) 
COMBINEDf 13,835 18-91 32.6 (12.1) 4921 (36) 8913 (64) 1627 (14) 2023 (18) 7937 (69) 3111 (23) 
a Number of participants missing data on age: MAL-HNW (n=4), MAL-HWW (n=1),  SAF (n=5), USA-IDU (n=9), VIE-FEM (n=23), VIE-IDU (n=1). 
b Number of participants missing data on sex: MAL-HNW (n=1). 
c Number of participants missing data on education: IND-SDW (n=1), NAM (n=1), USA-IDU (n=4), VIE-FEM (n=2).  
d For USA-IDU, categories are < High School, Some High School, >High School. 
e For NAM, HIV status based on self-report; for VIE-IDU, n=1 missing data on HIV status. 




Table 3. Mid-upper arm circumference (MUAC), body mass index (BMI), Pearson correlation coefficients, and  
Area under the ROC curve (AUROC), by individual study and for all studies combined 
Study ID 
MUAC (cm) BMI (kg/m2) BMI <18.5 Correlation 
coefficient AUROC 
Min - Max Mean (SD) Min - Max Mean (SD) N (%) 
ARG 21.3-48.0 28.7 (3.6) 17.6-45.8 24.0 (3.8) 3 (1.5) 0.85 0.98 
BAN 18.2-39.0 25.5 (3.1) 14.4-44.7 21.0 (3.7) 190 (29.2) 0.84 0.90 
GUI-HIV 11.6-42.2 26.0 (4.4) 11.3-45.7 20.3 (4.3) 391 (37.4) 0.87 0.95 
GUI-TBC 20.2-47.2 29.9 (4.3) 16.2-50.9 24.7 (4.8) 31 (4) 0.85 0.91 
IND-BKW 19.6-32.6 24.6 (2.1) 14.6-30.3 20.1 (2.4) 123 (24.6) 0.84 0.92 
IND-FSD 14.5-37.1 22.7 (3.2) 12.7-32.9 19.6 (3.7) 153 (45.9) 0.80 0.91 
IND-IDU 13.1-39.8 24.4 (3.3) 12.8-31.3 18.7 (3.0) 198 (53.2) 0.81 0.92 
IND-MSD 13.6-39.4 25.0 (2.9) 11.6-33.5 20.3 (3.3) 156 (32.9) 0.84 0.92 
IND-ORA 14.4-27.6 23.5 (2.0) 15.3-25.0 18.0 (1.6) 133 (64.9) 0.45 0.78 
IND-SDW 14.5-43.6 23.4 (3.1) 9.0-50.8 21.7 (4.1) 231 (23.3) 0.72 0.89 
IND-UNI 14.3-43.7 25.2 (3.3) 8.5-38.6 22.0 (3.7) 90 (15) 0.74 0.86 
MAL-HNW 22.4-36.6 26.9 (2.6) 18.1-41.4 22.7 (3.3) 1 (0.3) 0.82 0.95 
MAL-HWW 14.0-23.0 19.7 (1.8) 11.1-23.1 16.4 (1.9) 161 (89) 0.68 0.79 
NAM 17.0-42.0 27.8 (3.6) 13.8-62.2 23.0 (5.1) 35 (8.7) 0.53 0.79 
SAF 18.4-55.6 32.7 (6.4) 14.1-59.4 31.4 (8.2) 15 (5.4) 0.89 0.96 
USA-HIV 20.3-57.0 31.8 (5.1) 15.3-57.1 26.5 (5.7) 17 (3.1) 0.86 0.98 
USA-IDU 17.6-50.0 31.5 (4.9) 15.2-61.5 27.7 (6.5) 18 (3.5) 0.84 0.95 
VIE-FEM 16.0-40.0 24.5 (2.3) 14.5-32.6 19.6 (2.0) 1545 (31.4) 0.84 0.91 
VIE-IDU 17.5-34.5 25.5 (2.7) 13.5-31.7 20.2 (2.4) 78 (26.3) 0.80 0.88 
ZAM 13.3-25.0 20.6 (1.5) 10.7-22.2 16.9 (1.6) 162 (89) 0.46 0.61 
COMBINED 11.6-57.0 25.7 (4.2) 8.5-62.2 21.2 (4.6) 3731 (28.4) 0.85 0.91 
 
 aNumber of participants missing data on BMI: GUI-HIV (n=10), GUI-TBC (n=3), IND-IDU (n=2), MAL-HWW (n=5),  






Table 4. Summary Estimates of SENS, SPEC, positive likelihood ratio (LR+)a and negative  
likelihood ratio (LR-)b at selected MUAC cutoffs for all studies combined 
 
MUAC (cm) SENS SPEC LR+ LR- 
# 
Studies 
≤19.0 4.9 (2.2, 10.5) 99.7 (99.2, 99.9) 16.7 (5.7, 48.6) 1.0 (0.9, 1.0) 15 
≤19.5 7.9 (4.1, 14.7) 99.6 (99.0, 99.9) 20.8 (9.2, 46.9) 0.9 (0.9, 1.0) 15 
≤20.0 11.3 (6.0, 20.2) 99.6 (98.9, 99.9) 31.8 (13.2, 76.4) 0.9 (0.8, 1.0) 16 
≤20.5 16.0 (9.4, 26.0) 99.3 (98.3, 99.7) 22.9 (11.6, 45.0) 0.8 (0.8, 0.9) 17 
≤21.0 22.8 (13.9, 35.1) 99.0 (97.5, 99.6) 22.1 (12.2, 40.2) 0.8 (0.7, 0.9) 18 
≤21.5 31.0 (20.0, 44.7) 98.4 (95.7, 99.4) 19.6 (9.2, 41.8) 0.7 (0.6, 0.8) 19 
≤22.0 45.5 (29.9, 62.0) 96.4 (89.7, 98.8) 12.7 (5.8, 27.8) 0.6 (0.4, 0.7) 19 
≤22.5 58.1 (37.7, 76.1) 94.7 (85.2, 98.3) 11.1 (5.1, 24.1) 0.4 (0.3, 0.7) 20 
≤23.0 64.8 (47.0, 79.3) 93.3 (86.4, 96.9) 9.7 (5.8, 16.4) 0.4 (0.2, 0.6) 19 
≤23.5 75.1 (61.2, 85.2) 89.0 (79.4, 94.4) 6.8 (4.0, 11.6) 0.3 (0.2, 0.4) 19 
≤24.0 84.1 (74.1, 90.8) 83.2 (71.7, 90.7) 5.0 (3.1, 8.1) 0.2 (0.1, 0.3) 19 
≤24.5 89.9 (82.1, 94.6) 77.4 (64.1, 86.8) 4.0 (2.5, 6.3) 0.1 (0.1, 0.2) 19 
≤25.0 92.9 (87.7, 96.0) 73.3 (61.8, 82.3) 3.5 (2.4, 5.0) 0.1 (0.1, 0.2) 18 
≤25.5 95.7 (92.0, 97.7) 66.7 (53.8, 77.6) 2.9 (2.0, 4.1) 0.1 (0.0, 0.1) 18 
≤26.0 97.6 (94.6, 98.9) 58.7 (44.8, 71.3) 2.4 (1.7, 3.2) 0.0 (0.0, 0.1) 18 
≤26.5 98.0 (95.7, 99.1) 51.0 (37.3, 64.6) 2.0 (1.5, 2.6) 0.0 (0.0, 0.1) 18 
a Positive Likelihood Ratio (LR+) = ratio between the probability of MUAC ≤cutoff given BMI <18.5 and the probability of  
   MUAC ≤cutoff given BMI≥18.5 = SENS / (1-SPEC) 
b Negative Likelihood Ratio (LR-) = ratio between the probability of MUAC >cutoff given BMI <18.5 and the probability of  







Table 5. Comparing False Negative (FN) and False Positive (FP) Rates between Various 











































23.0 35 7 28 10 28 10 46 5 25 6 58 2 29 6 
23.5 25 11 19 16 19 17 36 8 17 10 43 3 22 10 
24.0 16 17 12 24 12 24 24 13 12 15 32 7 15 17 
24.5 10 23 7 32 8 32 16 19 8 19 24 9 11 22 
25.0 7 27 4 43 5 37 11 22 5 26 20 13 9 19 
25.5 4 33 2 51 3 45 6 28 3 32 16 16 4 24 
a Excludes studies with low (<10%) prevalence of individuals with BMI <18.5 (ARG, GUI-TBC, MAL-HNW, 
NAM, SAF, USA-HIV, and USA-IDU) or a low prevalence (<11%) of individuals with normal to high BMI 
(MAL-HWW, ZAM)   
b LMIC = low and middle-income countries only (Excludes the following upper middle and high-income 
countries: ARG, NAM, SAF, USA-HIV, AND USA-IDU) 
c FN = percentage of individuals with BMI<18.5 kg/m2 who are missed using the MUAC cutoff. 







Figure 1. Receiver operating characteristic curve for all studies included in the  
individual participant data meta-analysis (IPDMA) combined. Area under ROC curve = 0.91 
 
